Pitfalls with 18F-choline PET/CT in patients with prostate cancer

The (18)F-choline PET-CT (FCH) has better performance in the assessment of patients with prostate cancer than (18)F-FDG. However, similarly, it is also not a tumor specific radiotracer. We present four (18)F-FCH PET-CT scans in which false positive findings were correctly assessed after evaluation w...

Full description

Saved in:
Bibliographic Details
Published inRevista espanola de medicina nuclear e imagen molecular Vol. 32; no. 1; p. 37
Main Authors García Vicente, A M, Núñez García, A, Soriano Castrejón, A M, Jiménez Londoño, G A, Cordero García, J M, Palomar Muñoz, A
Format Journal Article
LanguageSpanish
Published Spain 01.01.2013
Subjects
Choline - analogs & derivatives
False Positive Reactions
Fluorine Radioisotopes
Humans
Male
Multimodal Imaging
Positron-Emission Tomography - methods
Prostatic Neoplasms - diagnosis
Tomography, X-Ray Computed - methods
Online AccessGet more information

Cover

More Information
Summary:The (18)F-choline PET-CT (FCH) has better performance in the assessment of patients with prostate cancer than (18)F-FDG. However, similarly, it is also not a tumor specific radiotracer. We present four (18)F-FCH PET-CT scans in which false positive findings were correctly assessed after evaluation with CT, clinical parameters and/or histological analysis.
ISSN:2253-8070